Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +22 vs. previous quarter
- 297
- 13F valueReported value at the end of Q2 2026
- $2.13B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BHVN, Q2 2026
No superinvestor reported holding BHVN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Biohaven Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 (view filing) | Mar 4, 2025 | 370 days | Childs John WDirector | PPurchase | +28.4K | $30.43 | +$864.2K | +1.2%2.32M after | Amended |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Clark George C.VP, Chief Accounting Officer | PPurchase | +17.0K | $8.52 | +$144.8K | +566.7%20.0K after | |
| Nov 17, 2025 (view filing) | Nov 13 | 4 days | Bailey GregoryDirector | PPurchase | +400.0K | $7.50 | +$3.00M | +24.7%2.02M after | |
| Nov 17, 2025 (view filing) | Nov 13 | 4 days | Coric VladChief Executive Officer | PPurchase | +666.7K | $7.50 | +$5.00M | +902.4%740.5K after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 13 | 4 days | Childs John WDirector | PPurchase | +3.33M | $7.50 | +$25.0M | +143.6%5.65M after | |
| Mar 5, 2025 (view filing) | Apr 22, 2024 | 317 days | Childs John WDirector | PPurchase | +73.2K | $41.00 | +$3.00M | New position73.2K after | Amended |
| Dec 31, 2024 (view filing) | Dec 30 | 1 day | Childs John WDirector | PPurchase | +29.0K | $35.94 | +$1.04M | +1.2%2.37M after | |
| Oct 3, 2024 (view filing) | Oct 2 | 1 day | Childs John WDirector | PPurchase | +21.1K | $47.50 | +$1.00M | New position21.1K after | |
| Oct 3, 2024 (view filing) | Oct 2 | 1 day | Coric VladChief Executive Officer | PPurchase | +21.1K | $47.50 | +$1.00M | +2.5%861.9K after | |
| Sep 25, 2024 (view filing) | Sep 24 | 1 day | Bailey GregoryDirector | PPurchase | +5.00K | $44.19 | +$220.9K | +0.3%1.62M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Biohaven Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,210,585 | $196.6M | 0.00% | +1,988,178+17.7% | Added |
| Suvretta Capital Management, LLC | 10,286,937 | $153.1M | 3.22% | 00.0% | Unchanged |
| Stifel Financial Corp | 9,941,165 | $147.9M | 0.12% | +2800.0% | Added |
| Jupiter Topco LLC | 8,584,675 | $127.9M | 0.05% | +8,584,675 | New |
| Woodline Partners LP | 7,660,280 | $114.0M | 0.35% | +7,359,891+2,450.1% | Added |
| State Street Corp | 6,947,034 | $103.4M | 0.00% | +328,231+5.0% | Added |
| Infinitum Asset Management, LLC | 6,250,000 | $93.0M | 9.46% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 4,190,195 | $62.4M | 0.04% | +1,343,002+47.2% | Added |
| AQR Capital Management LLC | 4,150,616 | $61.8M | 0.02% | +2,175,100+110.1% | Added |
| Geode Capital Management, LLC | 3,323,190 | $49.5M | 0.00% | +555,427+20.1% | Added |